Jul 2026
FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic Cholangiocarcinoma.
Mechanistic insights are provided into the paradox between the oncogenic properties of FGFR2 fusion and favorable clinical outcomes in FGFR2 fusion-positive iCCA, and a potential strategy to optimize FGFR2-targeted therapies is suggested.
Tao Zhu, Jia-Cheng Lu, Yan-Zi Pei et al.
· Cancer Letters · 0 citations